Fri, Jul 1, 7:33 AM, Zacks
Akers Biosciences Chlamydia Rapid Test Results Positive
Shares of Akers Biosciences Inc. (AKER) surged 15.8% to close at $3.22 following the completion of a clinical trial on the company's Chlamydia rapid test.
Tue, Jun 28, 5:49 AM, Zacks
Akers Biosciences Signs Distribution Agreement, Shares Rally
Akers Biosciences Inc. (AKER) recently signed an agreement with Aero-Med, a division of Cardinal Health (CAH), to distribute its disposable breathalyzer.